ARCHIVES

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

June 30, 2006

Broder Responds To AACR Proposal, Cites Congressional ‘Commitment’

December 6, 1991

Triple Combination Chemotherapy Effective For Advanced Colorectal Cancer, Trial Finds

January 27, 2006

Radiation Doesn’t Add Benefit For Early Endometrial Cancer

June 29, 2007

Letter to the Editor: Colleagues describe Bunn As Leader, Patient Advocate

January 12, 1996

Stand Up To Cancer Co-Founder Laura Ziskin Dies of Complications From Breast Cancer at 61

June 17, 2011